Clinical Trial

Lenalidomide Combined With G-CHOP in the Treatment of Newly Diagnosed DLBCL With FL

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
To evaluate the efficacy and adverse effects of lenalidomide combined with G-CHOP(LO-CHOP) in the treatment of newly diagnosed diffuse large B-cell lymphoma with follicular lymphoma (CDLBCL-FL).
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-11-28; most recent amendment 2025-02-18.
Trial Details
NCT Number NCT06151080
Lead Sponsor The First Affiliated Hospital of Xiamen University
Collaborators: The First Affiliated Hospital with Nanjing Medical University, Sun Yat-sen University, Jiangxi Provincial Cancer Hospital, Fujian Cancer Hospital
Conditions DLBCL - Diffuse Large B Cell Lymphoma, Follicular Lymphoma
Enrollment 38 participants
Start Date 2023-11-22
Primary Completion 2027-08-31 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-02-19